[go: up one dir, main page]

NO20003220L - Pharmaceutical preparations comprising micelles including lipophilic glucocorticosteroid and only one surfactant - Google Patents

Pharmaceutical preparations comprising micelles including lipophilic glucocorticosteroid and only one surfactant

Info

Publication number
NO20003220L
NO20003220L NO20003220A NO20003220A NO20003220L NO 20003220 L NO20003220 L NO 20003220L NO 20003220 A NO20003220 A NO 20003220A NO 20003220 A NO20003220 A NO 20003220A NO 20003220 L NO20003220 L NO 20003220L
Authority
NO
Norway
Prior art keywords
surfactant
pharmaceutical preparations
including lipophilic
micelles including
lipophilic glucocorticosteroid
Prior art date
Application number
NO20003220A
Other languages
Norwegian (no)
Other versions
NO20003220D0 (en
Inventor
Gabrielle Sjoequist
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20003220D0 publication Critical patent/NO20003220D0/en
Publication of NO20003220L publication Critical patent/NO20003220L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20003220A 1997-12-22 2000-06-21 Pharmaceutical preparations comprising micelles including lipophilic glucocorticosteroid and only one surfactant NO20003220L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9704833A SE9704833D0 (en) 1997-12-22 1997-12-22 New formulation
PCT/SE1998/002426 WO1999032089A1 (en) 1997-12-22 1998-12-22 Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant

Publications (2)

Publication Number Publication Date
NO20003220D0 NO20003220D0 (en) 2000-06-21
NO20003220L true NO20003220L (en) 2000-08-22

Family

ID=20409536

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003220A NO20003220L (en) 1997-12-22 2000-06-21 Pharmaceutical preparations comprising micelles including lipophilic glucocorticosteroid and only one surfactant

Country Status (20)

Country Link
EP (1) EP1043973A1 (en)
JP (1) JP2001526210A (en)
KR (1) KR20010024789A (en)
CN (1) CN1283106A (en)
AR (1) AR017220A1 (en)
AU (1) AU1993599A (en)
BR (1) BR9813811A (en)
CA (1) CA2315782A1 (en)
EE (1) EE200000388A (en)
HU (1) HUP0102365A3 (en)
ID (1) ID26945A (en)
IL (1) IL136880A0 (en)
NO (1) NO20003220L (en)
NZ (1) NZ505073A (en)
PL (1) PL341361A1 (en)
SE (1) SE9704833D0 (en)
SK (1) SK9532000A3 (en)
TR (1) TR200001977T2 (en)
WO (1) WO1999032089A1 (en)
ZA (1) ZA9811461B (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9902674D0 (en) * 1999-07-12 1999-07-12 Astra Ab New composition
SE0000332D0 (en) * 2000-01-31 2000-01-31 Astrazeneca Ab New use
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6787532B2 (en) * 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6777400B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
AU2001275760B2 (en) 2000-08-05 2005-03-17 Glaxo Group Limited 6.alpha., 9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl) oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid S-fluoromethyl ester as an anti-inflammatory agent
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
SE0100901D0 (en) * 2001-03-15 2001-03-15 Astrazeneca Ab New composition
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
BR0209271A (en) 2001-04-30 2004-06-15 Glaxo Group Ltd Compound, use of a compound pharmaceutical composition, pharmaceutical aerosol formulation, method for treating a human or animal patient with an inflammatory and / or allergic condition, and process for preparing a compound
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
WO2005018607A1 (en) * 2003-08-20 2005-03-03 Ajinomoto Co., Inc. Medicinal preparation having improved dissolution properties
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
CN100579510C (en) * 2006-04-13 2010-01-13 新疆维吾尔自治区包虫病临床研究所 Novel precursor micellar preparation and its production method
PT2211896T (en) * 2007-11-13 2018-03-21 Meritage Pharma Inc Compositions for the treatment of gastrointestinal inflammation
US9050368B2 (en) 2007-11-13 2015-06-09 Meritage Pharma, Inc. Corticosteroid compositions
AU2009290656B2 (en) * 2008-09-12 2015-05-07 Critical Pharmaceuticals Limited Improvements in the absorption of therapeutic agents across mucosal membranes or the skin
CN101982168B (en) * 2010-11-02 2012-05-23 山东大学 Quercetin nano micelle preparation and preparation method thereof
CN102793678B (en) * 2011-05-26 2017-06-30 邓世明 A kind of preparation method of the Docetaxel injection without tween
DE102011108948A1 (en) * 2011-07-29 2013-01-31 Achim Göpferich Aqueous, colloidal solutions of lipophilic substances, in particular drug solutions
JP5456802B2 (en) * 2012-01-23 2014-04-02 株式会社Ｃａｃ Cell migration promoter and transdermal absorbent for wound treatment
WO2015008301A1 (en) * 2013-07-17 2015-01-22 Council Of Scientific & Industrial Research Pharmaceutical composition for the treatment of diminution of bone tissue
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
KR20180126582A (en) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 Steroid hormone pharmaceutical composition
KR102086316B1 (en) * 2019-09-09 2020-03-09 한국콜마주식회사 Cosmetic composition having excellent percutaneous absorption property

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0179583A1 (en) * 1984-10-04 1986-04-30 Merck & Co. Inc. A system for enhancing the water dissolution rate and solubility of poorly soluble drugs
US4994439A (en) * 1989-01-19 1991-02-19 California Biotechnology Inc. Transmembrane formulations for drug administration
AR002009A1 (en) * 1994-12-22 1998-01-07 Astra Ab PHARMACEUTICAL COMPOSITION, PROCEDURE FOR THE MANUFACTURE OF A PROLIPOSOMA POWDER AS USED IN SUCH COMPOSITION, PROCEDURE FOR LAMANUFACTURE OF SUCH COMPOSITION, USE OF SUCH PHARMACEUTICAL COMPOSITION IN THE MANUFACTURE OF A DISPOSAL MEDICINAL PRODUCT.

Also Published As

Publication number Publication date
EE200000388A (en) 2002-02-15
JP2001526210A (en) 2001-12-18
AU1993599A (en) 1999-07-12
EP1043973A1 (en) 2000-10-18
HUP0102365A3 (en) 2002-01-28
NZ505073A (en) 2002-09-27
KR20010024789A (en) 2001-03-26
CA2315782A1 (en) 1999-07-01
TR200001977T2 (en) 2000-12-21
CN1283106A (en) 2001-02-07
ZA9811461B (en) 1999-06-22
SE9704833D0 (en) 1997-12-22
WO1999032089A1 (en) 1999-07-01
HUP0102365A2 (en) 2001-11-28
SK9532000A3 (en) 2000-11-07
AR017220A1 (en) 2001-08-22
BR9813811A (en) 2000-10-03
ID26945A (en) 2001-02-22
NO20003220D0 (en) 2000-06-21
PL341361A1 (en) 2001-04-09
IL136880A0 (en) 2001-06-14

Similar Documents

Publication Publication Date Title
NO20003220L (en) Pharmaceutical preparations comprising micelles including lipophilic glucocorticosteroid and only one surfactant
IS5953A (en) Pharmaceutical preparations from microplated eplerenones
DK1015596T4 (en) Fusion proteins comprising HIV-1 Tat and / or Nef proteins
NO20014220L (en) <Kappa-agonist compounds and pharmaceutical preparations thereof
DE69831620D1 (en) Pharmaceutical preparations containing cannabinoids
NO20021401D0 (en) Conazoline compounds and pharmaceutical preparations containing such compounds
DE69814091D1 (en) PRE-ICONAZOLE CONTAINING PHARMACEUTICAL PREPARATIONS
FI954204A7 (en) Injectable liposomal pharmaceutical preparations
NO996133D0 (en) Oil-in-water vaccine formulations
ITMI982280A0 (en) SOME N-(2-APRIL-PROPIONIL)-SULFONAMIDES AND PHARMACEUTICAL PREPARATIONS WHICH CONTAIN THEM
DE69831486D1 (en) ANTIPROLIFERATIVE PREPARATIONS
NO992340D0 (en) Solid pharmaceutical compositions comprising a cyclosporin and an aniomic surfactant
NO993868D0 (en) 3-piperidyl-4-oxoquinazoline derivatives and medical preparations containing them
HUT77235A (en) Anti-parasitic preparations for dermal application and their preparation
DK1071407T3 (en) Lipophilic microparticles containing a protein drug or antigen and the same formulation
EE200200038A (en) Preserved pharmaceutical preparations
NO993315D0 (en) Rapidly releasing and taste-masking pharmaceutical dosage form
NO20011157D0 (en) Benzene derivatives and pharmaceutical uses thereof
ATE332132T1 (en) IMPROVED MEDICINAL PREPARATIONS CONTAINING RITONAVIR
PT1228039E (en) N-GUANIDINOALQUILAMIDES ITS PREPARATION ITS USE AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME
DE69926012D1 (en) PHARMACEUTICAL PREPARATIONS
NO994619L (en) Pharmaceutical mixtures
NO20003141D0 (en) Pharmaceutical mixtures
DK199901456A (en) Serine protease and topical retonoid preparations
DE69906934D1 (en) PHARMACEUTICAL PREPARATIONS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application